Recursion Pharmaceuticals RXRX. $6.17 Buy

283
Looking at the chart from a technical perspective, price is currently indicating opening up @ $6.17 this is a further gain of 5.82% from last Fridays close, when the price rose 5.8%.

If this holds then we are looking at a breakout from previous resistance marked by the upper blue line. The lower blue line marks multi year lows which are beyond the timeline of this chart.

Tipranks reported unusually large call options last Friday, suggesting traders are expecting price to increase. Short interest is currently quoted at a very high figure of 35.5% by MarketBeat, so if the current strong momentum in the stock continues short sellers will be likely to close their positions further accelerating the price.

I t should be noted that institutional investors hold a high % of the stock at 89.06% so the float is relatively small.

It should also be noted that other significant companies in the same space of Genome editing have been performing strongly over the past month, this sector could be the next one to boom in my opinion.

For further information regarding the fundamentals I refer you to an excellent post by Topgoptions on 16th June, I won’t repeat his findings here.

I’ve been accumulating shares over the past few weeks, on this breakout I will be adding to my position.



Wyłączenie odpowiedzialności

Informacje i publikacje przygotowane przez TradingView lub jego użytkowników, prezentowane na tej stronie, nie stanowią rekomendacji ani porad handlowych, inwestycyjnych i finansowych i nie powinny być w ten sposób traktowane ani wykorzystywane. Więcej informacji na ten temat znajdziesz w naszym Regulaminie.